Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1981-02-17
1982-08-03
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
A61K 31195
Patent
active
043427804
ABSTRACT:
2-Amino-2-fluoromethyl-3-(substituted)phenyl propionic acids and derivatives thereof are coadministered with dopamine for the treatment of schizophrenia, mania, tardive dyskinesia, anxiety, or depression.
REFERENCES:
patent: 3046300 (1962-07-01), Sletzinger et al.
patent: 3553258 (1971-01-01), Kaiser et al.
patent: 3746753 (1973-07-01), Krady et al.
Bey Philippe
Jung Michel
Frankhouser David E.
Friedman Stanley J.
McDonald Raymond A.
Merrell-Toraude et Cie
Stein William J.
LandOfFree
Method of depleting endogenous monoamines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of depleting endogenous monoamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of depleting endogenous monoamines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1468460